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The binding of five different mouse monoclonal anti-dinitrophenyl (DNP) IgGl monomers, in the presence and absence of DNP-glycine, to FqRII 
on the mouse macrophage-like cell line 5774 has been investigated. Membrane association constants were estimated using a competitive radioim- 
munoassay in which the ability of the IgGl monomers to block the binding of ‘2SI-labelled Fabs of the anti-FcyRII monoclonal antibody 2.4G2 
was monitored. The IgGl-FcyRII association constants ranged from (8 rt 1) x lo4 M-’ to (6 ir 2) x 10’ M-‘. No large differences in the IgGl- 
FcyRII association constants were measured for different IgGl antibodies or for any single IgGl antibody in the presence and absence of 
DNP-glycine. 
Fc receptor; Cell surface antigen; Anti-(Fc receptor) antibody; Macrophage; Cell surface binding ~uilib~~; Radioimmunoassay 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Although a body of evidence shows that major con- 
formational changes do not occur in immunoglobulins 
upon hapten or antigen binding [l], the possibility that 
occupation of the antigen binding regions causes 
changes in Fc region effector functions, such as Fc re- 
ceptor binding and complement activation, has not been 
completely ruled out [2-6]. In addition, previous investi- 
gations have often used either polyclonal IgG or only 
one monoclonal antibody of a given IgG subclass to 
examine the association constants of IgG-FcyRII inter- 
actions [7-l 11, but the affinity of Fc regions for Fc 
receptors might, in theory, differ somewhat between 
different antibodies within a given subclass. In this 
work, potential differences in the equilibrium associa- 
tion constants for different monoclonal IgGl anti-dini- 
trophenyl (DNP) antibodies with a mouse Fc receptor, 
FcyRII [7,12], were investigated. The effects of the oc- 
cupation of the hapten binding regions on the IgG- 
FcyRII association constants were also examined. As- 
sociation constants for the mouse IgGl antibodies were 
measured on cells of the macrophage-related line 5774 
using a competitive radioimmune assay with 12%la- 
belled Fabs of the anti-FcyRII monoclonal antibody 
2.462 [13]. A preliminary report has appeared in ab- 
stract form [14]. 
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2.1. Ceils 
J774A.1, a macrophage-related cell line which expresses FcyRII, 
was obtained from the University of North Carolina Tissue Culture 
Facility. 2.462, a rat-mouse hybridoma which secretes antibodies 
specific for FcyRII [13f, was a gift from B. Diamond of the Albert 
Einstein College of Medicine. Five different hybridomas which pro- 
duce anti-DNP IgGl were obtained as follows: AN02, AN05, and 
AN06, H.M. McConnell, Stanford University [15,16]; lB7.11, Amer- 
ican Type Culture Collection; and DAK109.3, N.R. Klinman, Scripps 
Clinic and Research Foundation [17]. J774 and hybridoma cells were 
maintained in media supplemented with 1 mM sodium pyruvate, 2 
mM L-glutamine, 100 IU penicillin, lOO,ug/ml streptomycin, and fetal 
calf serum (FCS) that had been heat-inactivated for 30 min at 56”C, 
as follows: J774, AN02, and lB7.11, DME~Fl2, 5% FCS; ANOS, 
RPM1 1640,2.5% FCS; AN06 and DHK109.3, RPM1 1640,1% FCS. 
2.2. Antibodies 
Mouse IgG, rat IgG Fab, and mouse IgG F(ab); were obtained 
commercially (Jackson ImmunResearch, West Grove, PA). 2.462 an- 
tibodies were purified from cell su~~atants by affinity chromatogra- 
phy using an anti-(rat ~uno~obylin K light chain) antibody (MAR 
18.5), and 2.462 Fabs were produced and purified, as described [IS]. 
Anti-DNP IgGl were isolated from cell supematants by DNP-(human 
serum albumin) affinity chromatography [19]. Antibody isotypes were 
confirmed using the EIA Grade Mouse Typer System (Bio-Rad, 
Richmond, CA). All antibodies were clarified for 30 min at 
134,000 x g before use. Gel titration [20] showed that the antibodies 
eluted with symmetrical peaks corresponding to IgG monomers. IgGl 
concentrations were determined by spectrophotometry (&280 = 1.4 
ml . mg-’ . cm-‘). Antibodies were labelled with “‘1 (New England 
Nuclear, Wilmington, DE) using iodo-beads (Pierce Chemical, Rock- 
ford, IL). 8&95% of the ‘*‘I in chromatographed protein solutions 
was shown to be precipitated by trichloracetic acid. Specific activities 
were about 5 x 10’ cpm&g. IgG oligomers were formed by crosslink- 
ing solutions at 0.5 mg/mI in phosphat~buffered saline (PBS; 0.05 M 
sodium phosphate, 0.15 M sodium chloride, 0.01% sodium azide, pH 
7.4) with an 800-fold molar excess of disuccinimidylsuberate (DSS) 
(Pierce) for 1 h at 25’C, followed by chromatography on Sephadex 
G-25 in PBS and SDS-PAGE to confirm oligomer formation. The 
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association constants for IgGl antibodies and DNP-glycine (DNP-G) 
were measured by ultraviolet fluorescence quenching [191. 
2.3. Binding assays 
Aliquots of lo6 5774 cells in duplicate were washed with 1.5 ml 
medium (DMEMIFl2, 1% FCS, 0.01% NaN,) and resuspended in200 
,~l PBS containing ‘251-labelled antibodies, 1.5 mg/ml BSA/PBS, and 
in some cases unlabelled antibodies and/or DNP-G. For direct binding 
measurements, the solutions contained [‘251]-(2.4G2 Fab), [“‘I]- 
(2.462), [“‘I]-(rat IgG Fab), [12SI](-DSS-IgG); for inhibition measure- 
ments, the solutions contained an ‘2SI-labelled protein and either 
mouse IgG, anti-DNP IgGl, 2.4G2 Fab, or mouse IgG F(ab); with 
or without DNP-G (concentrations as specified). After reaction for 
various times (as noted), cells were pelleted, 50 ,~l supematant was 
reserved for later analysis, and then cells were washed three times in 
1.5 ml medium (twice without, and once with resuspension). Centrifu- 
gations were at 15,000 x g for l-2 min. Assays were carried out at 
&4”C. Radioactivities were measured in a liquid scintillation counter 
(Packard TriCarb 2000) Downers Grove, IL) using ScintiVerse Bio- 
HP fluid (Fisher Scientific, Springfield, NJ). 
2.4. Data analysis 
Binding curves were fit to theoretical forms using ASYST software 
(Rochester, NY). All experimental uncertainties are standard devia- 
tions. Data of the type shown in Figs. 1 through 3 were analyzed as 
described [21]. 
3. RESULTS 
3.1. [‘“I]-(2.4G2 Fab) and [“51]-(2.4G2) binding to 
J774 cells 
Measurements of the time dependence of [“‘I]-(2.4G2 
Fab) binding to 5774 cells indicated that apparent equi- 
librium was reached after about 20 min, consistent with 
previous work [22]. Subsequent assays were carried out 
by allowing [“‘I]-(2.4G2 Fab) to equilibrate with 5774 
cells for one hour. Comparison of the radioactivities of 
solutions equilibrated with cell suspensions to those of 
calibrated [rZSI]-(2.4G2 Fab) solutions indicated that the 
5774 cells depleted the solution concentration of [rz51]- 
(2.462 Fab) by 1585%; thus, the concentration of free 
[‘251]-(2.4G2 Fab) was subsequently obtained from the 
measured radioactivities of cell supernatants. 
Cell pellet radioactivities indicated that [1251]-(2.4G2 
Fab) bound to 5774 cells in a saturable manner (Fig. 1). 
Averaging the best-fit values obtained from five inde- 
pendently measured binding curves gave an association 
constant (&) of (1.5 + 0.5) x lo9 M-‘. The concentra- 
tion of bound [“‘I]-(2.4G2 Fab) at saturation is 
5.4 + 1.3 nM (Q), which corresponds to (6.5 + 1.6) 
x lo5 FcyRIIlcell. These values for Kr and Q agree well 
with previous measurements [7,23]. Failure to account 
for the cellular depletion of the solution of [1251]-(2.4G2 
Fab) gave association constants that were artifactually 
low by a factor of ten. 
The best fits of two independently obtained binding 
curves for intact [1251]-(2.4G2) to the functional form for 
a reversible bimolecular reaction gave an association 
constant of (4.1 + 2.0) x lo9 M-l and a saturating den- 
sity of (3.7 + 0.4) x lo5 molecules/cell. This value for & 
is only slightly larger than the measured constant for 
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Fig. 1. [‘251]-(2.4G2 Fab) binding to 5774 cells. For cells treated with 
various concentrations of [‘251]-(2.4G2 Fab) for 1 h, cell pellet radioac- 
tivities approached saturation at concentrations 2 10 nM and were 
very low for [‘*‘I]-(rat IgG Fab). The association constant of this curve 
is lo9 M-l. 
[1251]-(2.4G2 Fab), suggesting that a fraction of the 
bound [“‘I]-(2.4G2 IgG) may not have bound to the cell 
surface in a bivalent manner. Previous work has yielded 
similar association constants for intact 2.402, 2.462 
F(ab)> and 2.462 Fab on 5774 surfaces [13,24]. 
The specificity of [*2s1]-(2.4G2 Fab) binding was con- 
firmed in that the cell pellet radioactivity was reduced 
50-fold for [“51]-(rat IgG Fab) (160 nM, 1 h) (Fig. 1). 
In addition, a loo-fold excess of unlabelled 2.462 Fab 
reduced [1251]-(2.4G2 Fab) binding 45-fold (200 nM, 1 
h), and the measured association constant (&) did not 
change for [1251]-(2.4G2 Fab) solutions that were diluted 
lo-fold with unlabelled 2.4G2 Fab (ratio = 0.9 & 0.6). 
Greater than 98% of cell-bound [12sI]-(2.4G2 Fab) (2 
nM, 30 min) was eluted by a low pH buffer, indicating 
that significant internalization did not occur. 
3.2. Monoclonal anti-DNP IgGl binding to 3774 cells 
Cell binding assays with 2 nM [1251]-(2.4G2 Fab) in 
the presence of 30 PM DHK109.3 showed that apparent 
equilibrium was reached in 2-3 h. Subsequent competi- 
tion assays were carried out with three hour incubation 
times. As shown in Fig. 2, the monoclonal anti-DNP 
IgGl antibody AN02 partially blocked [“‘I]-(2.4G2 
Fab) binding, but the blocking was not complete at the 
maximum antibody concentration (30pM). In addition, 
as [‘251]-(2.4G2 Fab) binding was blocked, the cell su- 
pernatant radioactivity increased (Fig. 3). Similar re- 
sults were also measured for the other four anti-DNP 
IgGl monoclonal antibodies. 
Curve-fitting analysis of the cell pellet radioactivities 
gave values for the IgGl-FcyRII association constant, 
Km ranging from 8 x lo4 M-r (for DHK109.3) to 6 x lo5 
M-’ (for AN05) (Table I). Analysis of the cell superna- 
tant radioactivities gave consistent results. 
Volume 333, number 1,2 FEBS LETTERS October 1993 
3 
. 
z 
a 
h 
1.0 . 
-0 
c 0.0 I--__I 
0 5 10 15 20 25 30 35 
[AN021 (PM) 
Fig. 2. Pellet data for IgGl binding to 5774 cells. The pellet radioactiv- 
ities decreased when cells were treated for 3 h with 2 nM [‘251]-(2.4G2 
Fab) and increasing amounts of AN02. The association constant (K,,,) 
for this curve is 4.9 x 10’ M-’ with a Q of 3.2 nM. 
3.3 Effect of DNP-G on anti-DNP IgGl association con- 
stants 
The association constants of DNP-G with three of 
the five monoclonal IgGl antibodies were measured 
by tryptophan fluorescence quenching [181 and were as 
follows: lB7.11, (6.6 + 0.8) x lo6 M-‘; AN02, (2.9 & 0.2) 
x lo6 M-‘; DHK109.3, (2.3 ? 0.3) x lo5 M-‘. The de- 
gree of fluorescence quenching for the other two anti- 
bodies (AN05 and AN06) was approximately equal to 
the amount of quenching measured for mouse IgG. 
However, these antibodies did bind to DNP (in that the 
antibodies were purified using DNP affinity chromatog- 
raphy). Therefore, the association constants for AN05 
and AN06 were assumed to be about lo4 M-‘. The 
IgGl -(DNP-G) association constants implied that 
Table I 
Association constants K,,, for anti-DNP IgGl and FcyRII on 5774 
cells. Values for K,,, were obtained by analyzing cell pellet or supema- 
tant data using equations for reversible, bimolecular and competitive 
interactions between [‘251]-(2.4G2 Fab) and FcyRII and between 
mouse IgGl and FcyRII [21]. Values are in units of 10’ M-l. Values 
in parentheses give the number of independently obtained binding 
curves. 
Antibody Cell Pellet Supema- Cell Pellet Supema- Average 
DNP-G tant DNP-G tant 
(-) DNP-G (+) DNP-G 
(-) (+) 
AN05 5.7 r 4.5 
(3) 
AN02 3.3 k 0.6 
(2) 
AN06 1.6 + 0.5 
(2) 
lB7.11 1.3 + 0.6 
(3) 
DHK109.3 0.9 + 0.4 
(3) 
4.2 f 2.9 
(3) 
8.2 + 1.5 
(2) 
3.0 f 2.7 
(2) 
1.8 f 1.0 
(3) 
0.8 f 0.5 
(3) 
9.9 f 3.0 
(2) 
1.4 + 0.7 
(2) 
1.6 f 0.4 
(2) 
2.3 f 1.5 
(3) 
0.7 + 0.2 
(2) 
6.0 f 0.6 6.2 f 2.1 
(2) 
1.4 f 0.3 3.6 + 3.0 
(2) 
3.0 f 1.3 2.3 + 0.7 
(2) 
2.1 f 1.6 1.9 f 0.4 
(3) 
0.9 + 0.3 0.8 f 0.1 
(2) 
> 90% of the hapten binding sites were saturated at the 
chosen DNP-G concentrations (115 PM for AN02, 
lB7.11 and DHK109.3; 850pM for AN05 and AN06). 
Analysis of cell pellet and supernatant data gave con- 
sistent K,,, values. The values of K, in the presence of 
DNP-G were not significantly different from the values 
in the absence of DNP-G, within experimental error 
(Table I). 
3.4. Control Measurements for IgGl binding to 5774 
cells 
The specificity of monoclonal IgGl blocking of [1251]- 
(2.462 Fab) was examined by treating cells with [‘251]- 
(2.462 Fab) (2 nM) and mouse polyclonal IgG F(ab)‘, 
(2-26 ,uM). These measurements demonstrated that 26 
PM mouse IgG F(ab)‘, blocked less than 10% of the 
bound [‘251]-(2.4G2 Fab), indicating that the blocking 
data were Fc-specific. SDS-PAGE of overloaded gels 
visualized with silver staining showed that the 2.4G2 
Fab preparation contained very little intact 2.462. In 
addition, when [‘251]-(2.4G2 Fab) was mixed with 2 
mol% [‘251]-(2.4G2 IgG), DHK109.3 blocked the cell 
pellet radioactivity as effectively as with 100 mol% [‘251]- 
(2.462 Fab). Therefore, the incomplete blocking at long 
times and high IgGl concentrations was not due to 
[‘251]-(2.4G2 IgG) in the [‘251]-(2.4G2 Fab) solutions. 
Previous work has shown that monomeric, rabbit 
polyclonal IgG [8] and mouse myeloma IgGl, IgG2a 
and IgG2b [ 1 l] at 50 PM compete with and block > 90% 
of crosslinked, polyclonal rabbit IgG on P388D, cells. 
In this work, most of the monoclonal mouse IgGl (at 
30 PM) did not effectively block [‘*‘I]-(2.4G2 Fab) bind- 
ing. Thus, to examine whether the incomplete blocking 
was a property of the particular assay procedure used 
in this work, the ability of monomeric mouse IgG to 
block the binding of polyclonal mouse IgG that had 
been crosslinked with DSS and labelled with 1251 was 
0.00 ’ 8 _I 
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Fig. 3. Supematant data for IgGl binding to 5774 cells. The supema- 
tant radioactivities increased when cells were treated for 3 h with 2 nM 
[‘251]-(2.4G2 Fab) and increasing amounts of AN02. The association 
constant (&,,) for this curve is 7.1 x 10’ M-i. 
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investigated. These measurements howed that [1251]- 
(DSS-IgG) bound to 5774 cells in a concentration-de- 
pendent and saturable manner, and that 30 ,uM polyclo- 
nal mouse IgG blocked about 80% of the bound [lz51]- 
(DSS-IgG), confirming the validity of the assay proto- 
col. Thus, the observation that 30 PM anti-DNP IgGl 
blocked only about 50% of the bound [‘251]-(2.4G2 Fab) 
was most likely a simple consequence of the high [1251]- 
(2.462 Fab)-FcyRII association constant. 
4. DISCUSSION 
The measured values of K,,, for the five monoclonal 
IgGl antibodies with FcyRII on 5774 cell surfaces 
(Table I) are consistent with previous measurements for 
mouse myeloma IgGl on P388Di cells using competi- 
tive radioimmunoassays with 1251-labelled, cross-linked 
polyclonal rabbit IgG (3 x IO5 M-‘, O’C) [ll]. The K,,, 
values are also consistent with previous immunofluores- 
cence measurements for polyclonal IgG and monoclo- 
nal IgGl on planar model membranes constructed from 
isolated 5774 membrane fragments (l-5 x lo5 M-‘, 
25°C) [18] or from purified and reconstituted FcyRII 
(3-9 x 10’ M-‘, 25°C) [20]. 
As shown in Table I, no large differences between 
different monoclonal IgGl were detected within experi- 
mental error. The small differences that were observed 
in general arise from slightly altered Fc region confor- 
mations, flexibilities and/or solvent accessibilities. In 
addition, the binding of mouse macrophage (5774.1 and 
P388Di) to planar lipid monolayers coated with mono- 
clonal IgGl antibodies was not strongly different for 
seven different antibodies, but one antibody (lB7) 
lacked the ability to promote macrophage-monolayer 
binding [25]. The lB7 antibody is not equivalent o the 
lB7.11 antibody. (M. Nakanishi, personal communica- 
tions). 
The observation that multivalent IgG complexes bind 
with higher affinity to macrophage cell surfaces than 
monomeric IgG [l l] suggests that the key molecular 
event in the association of antibody-coated targets with 
macrophage cell surfaces (i.e. the onset of phagocytosis) 
is the multivalency of the target with respect o IgG Fc 
regions. However, in general, because previous experi- 
ments have been carried out primarily with crosslinked, 
multivalent IgG-antigen complexes [8,10], another pos- 
sibility is that occupation of the antigen binding site 
enhances the IgG-FcyRII interaction. The association 
constants of anti-DNP IgGl with FcyRII were not sig- 
nificantly affected by the presence of DNP-G at saturat- 
ing concentrations, and the data therefore argue against 
a mechanism in which Fab occupation effects changes 
in Fc region function. A related set of measurements 
using fluorescence microscopy and FcyRII that was 
purified and reconstituted into substrate-supported pla- 
nar membranes has given consistent results [26]. 
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